Christopher Rhodes to Biomarkers
This is a "connection" page, showing publications Christopher Rhodes has written about Biomarkers.
Connection Strength
0.990
-
Pulmonary hypertension: biomarkers. Handb Exp Pharmacol. 2013; 218:77-103.
Score: 0.282
-
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2022 05 01; 205(9):1102-1111.
Score: 0.135
-
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. Lancet Respir Med. 2017 09; 5(9):717-726.
Score: 0.096
-
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013 Feb 01; 187(3):294-302.
Score: 0.070
-
Formation of a human ß-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab. 2012 Sep; 97(9):3197-206.
Score: 0.068
-
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 Jul; 97(13):1054-60.
Score: 0.063
-
Cytokines as prognostic biomarkers in pulmonary arterial hypertension. Eur Respir J. 2023 03; 61(3).
Score: 0.036
-
High Plasma Levels of Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity. J Am Heart Assoc. 2023 02 07; 12(3):e8145.
Score: 0.035
-
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension. J Heart Lung Transplant. 2023 02; 42(2):173-182.
Score: 0.035
-
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine. 2021 Jul; 69:103444.
Score: 0.032
-
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019 03; 53(3).
Score: 0.027
-
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax. 2019 04; 74(4):380-389.
Score: 0.027
-
Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development. J Intern Med. 2017 08; 282(2):129-141.
Score: 0.024
-
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future. Pharmacol Ther. 2016 08; 164:195-203.
Score: 0.022
-
Association of synovial inflammation and inflammatory mediators with glenohumeral rotator cuff pathology. J Shoulder Elbow Surg. 2016 Jun; 25(6):989-97.
Score: 0.022
-
Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011 Mar; 31(2):95-107.
Score: 0.015